Anhui Anke Biotechnology Mutual Funds

Health Care & Life Sciences » Biotechnology | Anhui Anke Biotechnology

Anhui Anke Biotechnology | Mutual Funds

Mutual Funds that own Anhui Anke Biotechnology

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

lnvesco Great Wall Domestic Demand Growth II Fund

9,306,305

1.42%

991,480

7.85%

12/31/2017

7,036,260

1.07%

2,024,315

0.72%

12/31/2017

6,995,722

1.07%

3,685,020

1.95%

12/31/2017

6,661,112

1.02%

2,615,179

2.04%

12/31/2017

Invesco Great Wall Domestic Demand Growth Fund

4,924,213

0.75%

506,380

7.88%

12/31/2017

4,200,000

0.64%

4,200,000

2.81%

12/31/2017

E Fund Growth Enterprise Index ETF

2,790,411

0.43%

-364,000

0.94%

12/31/2017

2,680,153

0.41%

-476,560

0.86%

12/31/2017

China Universal Advantage Select Fund

2,519,800

0.39%

2,519,800

1.96%

12/31/2017

2,286,263

0.35%

2,286,263

2.4%

12/31/2017

About Anhui Anke Biotechnology

View Profile

Address	K-1, Haiguan Road Hefei Anhui 230088 China
Employees	-
Website	http://www.ankebio.com
Updated	07/08/2019
Anhui Anke Biotechnology (Group) Co., Ltd. engages in the research and development, manufacture, and sale of biopharmaceutical products. Its business activities include implementation of precision medical development strategy, formation of genetic testing, and development of anti-tumor drugs and cell immunotherapy technology. Its products consist of biological products, modern Chinese medicine, chemical synthetic drugs, peptide active pharmaceutical ingredients, nucleic acid detection, and cosmetic products.